1. Home
  2. DYN vs LTC Comparison

DYN vs LTC Comparison

Compare DYN & LTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYN
  • LTC
  • Stock Information
  • Founded
  • DYN 1984
  • LTC 1992
  • Country
  • DYN United States
  • LTC United States
  • Employees
  • DYN N/A
  • LTC N/A
  • Industry
  • DYN Medicinal Chemicals and Botanical Products
  • LTC Real Estate Investment Trusts
  • Sector
  • DYN Health Care
  • LTC Real Estate
  • Exchange
  • DYN Nasdaq
  • LTC Nasdaq
  • Market Cap
  • DYN 1.9B
  • LTC 1.7B
  • IPO Year
  • DYN 2020
  • LTC 1992
  • Fundamental
  • Price
  • DYN $14.51
  • LTC $34.51
  • Analyst Decision
  • DYN Strong Buy
  • LTC Hold
  • Analyst Count
  • DYN 14
  • LTC 5
  • Target Price
  • DYN $34.93
  • LTC $38.80
  • AVG Volume (30 Days)
  • DYN 2.5M
  • LTC 413.2K
  • Earning Date
  • DYN 11-11-2025
  • LTC 10-27-2025
  • Dividend Yield
  • DYN N/A
  • LTC 6.59%
  • EPS Growth
  • DYN N/A
  • LTC N/A
  • EPS
  • DYN N/A
  • LTC 1.81
  • Revenue
  • DYN N/A
  • LTC $213,197,000.00
  • Revenue This Year
  • DYN N/A
  • LTC N/A
  • Revenue Next Year
  • DYN N/A
  • LTC N/A
  • P/E Ratio
  • DYN N/A
  • LTC $19.13
  • Revenue Growth
  • DYN N/A
  • LTC 8.74
  • 52 Week Low
  • DYN $6.36
  • LTC $31.70
  • 52 Week High
  • DYN $35.90
  • LTC $39.89
  • Technical
  • Relative Strength Index (RSI)
  • DYN 59.18
  • LTC 37.24
  • Support Level
  • DYN $12.43
  • LTC $34.48
  • Resistance Level
  • DYN $14.27
  • LTC $37.25
  • Average True Range (ATR)
  • DYN 0.73
  • LTC 0.58
  • MACD
  • DYN 0.04
  • LTC -0.17
  • Stochastic Oscillator
  • DYN 85.53
  • LTC 12.64

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

About LTC LTC Properties Inc.

LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in seniors housing and healthcare facilities through mortgage loans, property lease transactions, and other investments. Its real estate investments includes different types of properties such as Independent living communities, Assisted living communities, Memory care communities, Skilled nursing centers and other types of properties.

Share on Social Networks: